The Impact of Vaccination in the US Should Be Felt in March, Says BioNTech CEO – 12/12/2020



[ad_1]

After the FDA (Food and Drug Administration) approves the launch of the emergency use of the vaccine against covid-19 produced by the pharmaceutical companies Pfizer and BioNTech, the expectation is that in the coming days the start of an important campaign will be announced. vaccination in the United States. .

But the impacts of this vaccine can only begin to be felt in a few months, probably around March of next year, according to Ugur Sahin, CEO of BioNTech. In an interview with CNN, Sahin said that Pfizer has only been able to produce a few million doses for the United States so far, and that the pandemic should not be immediately controlled by the immunizer.

“We will not have a direct impact on the spread of the pandemic in the coming months, as we need, of course, to reach a large proportion of the population to stop the outbreak,” he said.

But after more people are vaccinated, the more effects will be felt, he said. “It may be until early to mid-March before we see the first effects.”

Sahin said he hoped that with the arrival of spring in the United States in March next year, the country would “naturally have a lower infection rate.” Today, about to enter winter, the United States has registered a high number of cases and deaths from covid-19.

On Wednesday (9), the country registered more than 3,000 deaths from covid in a 24-hour period.

Vaccine release

In its decision, the FDA understood that the Pfizer immunizer, produced in association with BioNTech, “meets the legal criteria for release in the US.” And that “all the available data provide clear evidence that the vaccine can be effective in preventing covid-19”.

Shortly after the announcement of the association, the president of the United States, Donald Trump, published a statement on his Twitter account, praising the decision. “Our country has achieved a medical miracle,” he said.

Trump also promised that the first dose of the vaccine will be administered within 24 hours of its release by the FDA.

“We want our seniors, healthcare professionals and first responders to be first in line. This will quickly and dramatically reduce deaths and hospitalizations.”

[ad_2]